vs

Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and SOUTHERN FIRST BANCSHARES INC (SFST). Click either name above to swap in a different company.

SOUTHERN FIRST BANCSHARES INC is the larger business by last-quarter revenue ($31.8M vs $27.6M, roughly 1.2× Beta Bionics, Inc.). On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 26.1%).

Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

BBNX vs SFST — Head-to-Head

Bigger by revenue
SFST
SFST
1.2× larger
SFST
$31.8M
$27.6M
BBNX
Growing faster (revenue YoY)
BBNX
BBNX
+30.5% gap
BBNX
56.6%
26.1%
SFST

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BBNX
BBNX
SFST
SFST
Revenue
$27.6M
$31.8M
Net Profit
$-21.9M
Gross Margin
59.5%
Operating Margin
-47.4%
40.1%
Net Margin
-79.3%
Revenue YoY
56.6%
26.1%
Net Profit YoY
23.6%
EPS (diluted)
$-0.49
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBNX
BBNX
SFST
SFST
Q1 26
$27.6M
Q4 25
$32.1M
$31.8M
Q3 25
$27.3M
$31.1M
Q2 25
$23.2M
$28.6M
Q1 25
$17.6M
$26.5M
Q4 24
$25.2M
Q3 24
$23.8M
Q2 24
$23.1M
Net Profit
BBNX
BBNX
SFST
SFST
Q1 26
$-21.9M
Q4 25
$-13.5M
Q3 25
$-14.2M
$8.7M
Q2 25
$-16.9M
$6.6M
Q1 25
$-28.7M
$5.3M
Q4 24
Q3 24
$4.4M
Q2 24
$3.0M
Gross Margin
BBNX
BBNX
SFST
SFST
Q1 26
59.5%
Q4 25
59.0%
Q3 25
55.5%
Q2 25
53.8%
Q1 25
50.9%
Q4 24
Q3 24
Q2 24
Operating Margin
BBNX
BBNX
SFST
SFST
Q1 26
-47.4%
Q4 25
-50.2%
40.1%
Q3 25
-62.5%
36.4%
Q2 25
-85.5%
30.0%
Q1 25
-105.7%
26.1%
Q4 24
27.3%
Q3 24
24.1%
Q2 24
17.0%
Net Margin
BBNX
BBNX
SFST
SFST
Q1 26
-79.3%
Q4 25
-41.9%
Q3 25
-52.1%
27.8%
Q2 25
-72.6%
23.0%
Q1 25
-162.5%
19.9%
Q4 24
Q3 24
18.4%
Q2 24
13.0%
EPS (diluted)
BBNX
BBNX
SFST
SFST
Q1 26
$-0.49
Q4 25
$-0.16
$1.19
Q3 25
$-0.33
$1.07
Q2 25
$-0.39
$0.81
Q1 25
$-0.93
$0.65
Q4 24
$0.69
Q3 24
$0.54
Q2 24
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBNX
BBNX
SFST
SFST
Cash + ST InvestmentsLiquidity on hand
$199.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$271.2M
$368.7M
Total Assets
$304.4M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBNX
BBNX
SFST
SFST
Q1 26
$199.5M
Q4 25
$219.1M
Q3 25
$228.7M
Q2 25
$249.7M
Q1 25
$231.5M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
BBNX
BBNX
SFST
SFST
Q1 26
$271.2M
Q4 25
$287.6M
$368.7M
Q3 25
$294.8M
$356.3M
Q2 25
$301.6M
$345.5M
Q1 25
$313.8M
$337.6M
Q4 24
$330.4M
Q3 24
$326.5M
Q2 24
$318.7M
Total Assets
BBNX
BBNX
SFST
SFST
Q1 26
$304.4M
Q4 25
$328.7M
$4.4B
Q3 25
$330.0M
$4.4B
Q2 25
$330.0M
$4.3B
Q1 25
$338.0M
$4.3B
Q4 24
$4.1B
Q3 24
$4.2B
Q2 24
$4.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBNX
BBNX
SFST
SFST
Operating Cash FlowLast quarter
$30.5M
Free Cash FlowOCF − Capex
$29.9M
FCF MarginFCF / Revenue
93.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$62.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBNX
BBNX
SFST
SFST
Q1 26
Q4 25
$-8.6M
$30.5M
Q3 25
$-8.7M
$14.5M
Q2 25
$-13.6M
$10.5M
Q1 25
$-20.0M
$7.6M
Q4 24
$25.6M
Q3 24
$26.3M
Q2 24
$4.0M
Free Cash Flow
BBNX
BBNX
SFST
SFST
Q1 26
Q4 25
$-10.5M
$29.9M
Q3 25
$-10.0M
$14.4M
Q2 25
$-15.4M
$10.4M
Q1 25
$-20.3M
$7.4M
Q4 24
$24.8M
Q3 24
$26.1M
Q2 24
$3.9M
FCF Margin
BBNX
BBNX
SFST
SFST
Q1 26
Q4 25
-32.8%
93.8%
Q3 25
-36.7%
46.3%
Q2 25
-66.2%
36.3%
Q1 25
-115.1%
28.1%
Q4 24
98.2%
Q3 24
110.0%
Q2 24
16.8%
Capex Intensity
BBNX
BBNX
SFST
SFST
Q1 26
Q4 25
5.9%
1.8%
Q3 25
4.7%
0.3%
Q2 25
7.7%
0.3%
Q1 25
1.9%
0.5%
Q4 24
3.1%
Q3 24
0.8%
Q2 24
0.4%
Cash Conversion
BBNX
BBNX
SFST
SFST
Q1 26
Q4 25
Q3 25
1.67×
Q2 25
1.59×
Q1 25
1.44×
Q4 24
Q3 24
6.01×
Q2 24
1.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons